Orladeyo®

BOSTON, U.S. & CAMBRIDGE, U.K. — August 25, 2026 Apollo Therapeutics announced positive immunogenicity and cross-species activity data from...

BOSTON – October 14, 2025 – BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) and Astria Therapeutics, Inc. (NASDAQ: ATXS) announced a...